Björn Klocke – Trademark Portfolio

Entity Type: 01

Björn Klocke holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NEMICS.

Rigistrasse 27c

CH-8006 Zürich

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NEMICS
NEMICS
Registered 2023

Trademark Classifications

Björn Klocke's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Björn Klocke have?

Björn Klocke has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Björn Klocke file in?

Björn Klocke files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Björn Klocke's most well-known trademarks?

Björn Klocke's registered trademark portfolio includes well-known marks such as NEMICS. These are among 1 currently registered trademark in the portfolio.

What is Björn Klocke's trademark registration success rate?

Björn Klocke has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.